Author Archives: wpadmin

FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

Print this page RALEIGH, N.C.  –  May 13,  2019  –  Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA), broadening its indication to be a first-line treatment of blepharospasm (involuntary blinking) in adult patients. “Merz is proud to offer a first-line… Read More »

Could Assisted Living Help Your Loved One Suffering from Alzheimer’s or Dementia?

When a parent or loved one gets on in age, the concern of who is going to help them and how becomes an ever-present worry. Perhaps the loved one in question is self-reliant and doesn’t require an ever-present caretaker to assist them. Maybe you were able to take on the responsibility of helping them out.… Read More »

Tone deaf promotion of very early research on smartphone app for kids’ ear fluid

May 17, 2019 Posted By Categories Gary Schwitzer is founder and publisher of HealthNewsReview.org. STAT does some great stuff.  And some clunkers.  They get enough praise for the great stuff, but not enough scrutiny of the clunkers.  This is one such example. A story based on very preliminary research touted the early work in very… Read More »